Considering that the Ex4 treatment ameliorates the maladaptive behavior of cocaine, Glucagon-like peptide-1 agonists might be repurposed as an effective medication that can reduce the risks of relapse of cocaine use disorder. This evidence concerns the gene GCG and cocaine use disorder.